Older Men's Decision Making About Active Surveillance for Prostate Cancer
This study is looking at an educational tool designed to help men aged 65 or older with localized prostate cancer make decisions with their doctors. Specifically, it aims to help them decide if and when to reduce or stop active surveillance (regular check-ups and tests like biopsies or imaging). For many men, their prostate cancer may not need aggressive treatment, or their health might change, making less intensive monitoring a reasonable choice. This study will test different versions of this educational tool to see how well they prepare men for these important decisions. We are looking for men who have not yet received curative treatment for their prostate cancer and are fluent in English. Care partners or caregivers aged 18 or older who are also fluent in English can also participate.
- Study design
- This is an observational study with a planned enrollment of 180 participants. It uses a pre-post design to test the initial effectiveness of different versions of an educational tool.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, 'Preparation for Decision Making Scale,' is measured through study completion and an average of 1 year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Lisa Lowenstein, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Preparation for Decision Making ScaleThrough study completion and average of 1 year
The Preparation for Decision Making Scale (PrepDM)19 is a validated scale that assesses whether the decision aid helped prepare a patient to talk with their clinician in making a treatment decision. The scale has 10 items with a 5-point Likert response format, Score Scale 1 (not at all) and 5 (a great deal).